On-demand education
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
ASCO2024 special: Circulating kidney injury molecule-1 biomarker analysis in IMmotion010
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. Ciccarese
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. Marandino
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
UROONCO RCC take home message for 2023
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Special series: 3D models for kidney cancer with caval thrombous
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/ESU-On-Demand-Recorded-UROwebinar.png)
Recording: Impact of ERAS in Kidney cancer
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Special series: Vascular perfusion 3D models and augmented reality for RCC surgery
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)
Discussion with Prof. Badani at ERUS23 on RAPN
![](https://d56bochluxqnz.cloudfront.net/media/_600x208_crop_center-center_none/EAU-Podcasts_SM_Generic-Post_no-txt.png)